Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01849393 · ClinicalTrials.gov registry record

Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents

A clinical trial of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS), sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
100
Enrollment target
1
Study location

NCT01849393: Completed study of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS), sponsored by St. Jude Children's Research Hospital.

NCT01849393 is a study of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 100 participants, below the 503-participant average among 18 other Human Immunodeficiency Virus (HIV) trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01849393, a study of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS), has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this project is to assess the study population's acceptance of two medication adherence support strategies: incentive-based programs and electronic medication monitoring. The study population is adolescents (ages 16 - 24) positive for human immunodeficiency virus (HIV) currently undergoing treatment with antiretrovirals at St. Jude's HIV clinic. Participation in the study will involve completion of a survey: an Audio Computer Assisted Self Interview (ACASI). The duration of the survey is anticipated to be 10-20 minutes. Patient identifiers will not be attached the survey.

Primary Outcome

Participants will complete a survey/questionnaire on the computer describing their disease state, the frequency and amount of medication taken daily, and how well they comply with taking their medications and attending their clinic appointments. They will also note their perceptions about how incentive-based adherence programs and electronic medication monitoring. Descriptive statistics will be prepared from survey results.

Conditions Studied

Human Immunodeficiency Virus (HIV) Acquired Immunodeficiency Syndrome (AIDS)

Interventions

  • OTHER Questionnaire

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2013-06
Est. Completion 2013-12
St. Jude Children's Research Hospital

410 total trials

What the finished NCT01849393 record still lists

NCT01849393 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 503-participant average among 18 other Human Immunodeficiency Virus (HIV) trials with a reported enrollment target (80% lower).

The record links to 2 conditions, with Human Immunodeficiency Virus (HIV) appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.

NCT01849393 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT01849393 about?

NCT01849393 is a clinical study titled "Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents". The primary objective of this project is to assess the study population's acceptance of two medication adherence support strategies: incentive-based programs and electronic medication monitoring. The study population is adolescents (ages 16 - 24) positive for human immunodeficiency virus (HIV) curre...

What is the current status of trial NCT01849393?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-06. Estimated completion is 2013-12.

What conditions does trial NCT01849393 study?

This clinical trial studies the following conditions: Human Immunodeficiency Virus (HIV), Acquired Immunodeficiency Syndrome (AIDS).

What interventions are being tested in trial NCT01849393?

The interventions under investigation include: Questionnaire (OTHER).

Who is sponsoring clinical trial NCT01849393?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01849393 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Human Immunodeficiency Virus (HIV)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01849393's enrollment target sits among peer trials

100 11th of 18 higher than 8 of 18 other Human Immunodeficiency Virus (HIV) trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Human Immunodeficiency Virus (HIV) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01849393, the US trial registry maintained by the National Library of Medicine. NCT01849393 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.